# KEYTRUDA

NDC: 0006-3026
Generic name: pembrolizumab
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20150115

FDA application: BLA125514

## Active ingredients

- PEMBROLIZUMAB: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-3026"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-3026
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9333c79b-d487-4538-a9f0-71b91a02b287